M&T Bank’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,992
Closed -$419K 1658
2023
Q3
$419K Sell
3,992
-150
-4% -$19.2K ﹤0.01% 1155
2023
Q2
$532K Sell
4,142
-121
-3% -$18.4K ﹤0.01% 1094
2023
Q1
$745K Sell
4,263
-285
-6% -$51.1K ﹤0.01% 965
2022
Q4
$756K Buy
4,548
+429
+10% +$67.2K ﹤0.01% 954
2022
Q3
$580K Buy
4,119
+221
+6% +$40.3K ﹤0.01% 1023
2022
Q2
$795K Buy
3,898
+1,079
+38% +$236K ﹤0.01% 849
2022
Q1
$718K Buy
2,819
+1,606
+132% +$436K ﹤0.01% 858
2021
Q4
$399K Buy
1,213
+443
+58% +$139K ﹤0.01% 1121
2021
Q3
$232K Buy
+770
New +$219K ﹤0.01% 1368

Other funds holding MLAB

M&T Bank's MLAB Position: Q4 2023 in Review

M&T Bank sold out of Mesa Laboratories (MLAB) in Q4 2023, closing a stake of 3,992 shares — an estimated $419K sold.

M&T Bank first reported a position in MLAB in Q3 2021 and held it in 9 quarters. The position peaked at $795K in Q2 2022. 158 funds tracked by Wall St. Rank hold MLAB as of Q4 2023.

  • M&T Bank reported no remaining Mesa Laboratories position as of Q4 2023 after selling out during the quarter.
  • M&T Bank sold 3,992 Mesa Laboratories shares in Q4 2023, an estimated $419K.
  • M&T Bank first reported a position in Mesa Laboratories in Q3 2021 and held it in 9 quarters.
  • M&T Bank's Mesa Laboratories position peaked at $795K in Q2 2022.
  • 158 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2023.

Based on M&T Bank's 13F filing for Q4 2023, filed 6 Feb 2024.